These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1968387)

  • 1. Antigen density on target cells determines the immunosuppressive potential of rat IgG2b monoclonal antibodies.
    Kummer U; Thierfelder S; Mysliwietz J
    Eur J Immunol; 1990 Jan; 20(1):107-12. PubMed ID: 1968387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antilymphocytic antibodies and marrow transplantation. VII. Two of nine monoclonal anti-Thy-1 antibodies used for pretreatment of donor marrow suppressed graft-versus-host reactions without added complement.
    Thierfelder S; Cobbold S; Kummer U; Waldmann H; Schuh R
    Exp Hematol; 1985 Oct; 13(9):948-55. PubMed ID: 2864278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antilymphocytic antibodies and bone marrow transplantation. XI. Evidence that reduced Thy-1 expression in Thy-1.1 mice prevents suppression of graft-versus-host disease with anti-Thy-1 monoclonal antibodies.
    Mysliwietz J; Thierfelder S; Hoffmann-Fezer G; Kummer U
    Transplantation; 1990 Apr; 49(4):749-55. PubMed ID: 1970200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed against T cells or their subsets. I. Evidence for the induction of a state of tolerance based on suppression.
    Knulst AC; Tibbe GJ; Noort WA; Bril-Bazuin C; Benner R; Savelkoul HF
    Bone Marrow Transplant; 1994 Mar; 13(3):293-301. PubMed ID: 8199571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo immunosuppression by pan-T cell antibodies relates to their isotype and to their C1q uptake.
    Kummer U; Thierfelder S; Hoffmann-Fezer G; Schuh R
    J Immunol; 1987 Jun; 138(12):4069-74. PubMed ID: 2884259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antilymphocytic antibodies and marrow transplantation. IX. T-cell depletion in marrow donors with C1q high and low affinity antibodies for suppression of GVHD in fully mismatched mice.
    Antica M; Hoffmann-Fezer G; Thierfelder S
    Exp Hematol; 1989 Oct; 17(9):942-7. PubMed ID: 2570711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of lethal graft-vs.-host disease by a single low dose injection of anti-T cell monoclonal antibody to the allograft recipients.
    Knulst AC; Bril-Bazuin C; Benner R
    Eur J Immunol; 1991 Jan; 21(1):103-7. PubMed ID: 1671355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of acute graft-versus-host disease and re-establishment of tolerance by short-term treatment with an anti-TCR antibody.
    Maeda T; Eto M; Lin T; Nishimura Y; Kong YY; Nomoto K; Nomoto K
    J Immunol; 1994 Nov; 153(9):4311-20. PubMed ID: 7930630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the Thy-1 pathway of T cell hybridoma activation using 17 rat monoclonal antibodies reactive with distinct Thy-1 epitopes.
    Pont S; Regnier-Vigouroux A; Naquet P; Blanc D; Pierres A; Marchetto S; Pierres M
    Eur J Immunol; 1985 Dec; 15(12):1222-8. PubMed ID: 2417861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antilymphocytic antibodies and marrow transplantation. XIV. Antibody-induced suppression of graft-versus-host disease in C3-decomplemented mice differentiates two T-cell-depletion pathways.
    Thierfelder S; Mysliwietz J; Hoffmann-Fezer G; Kummer U
    Blood; 1991 May; 77(10):2285-91. PubMed ID: 2029584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to nonpolymorphic determinants of the Thy-1 molecule inhibit T cell proliferation.
    Hollander N
    J Immunol; 1985 May; 134(5):2916-21. PubMed ID: 2858507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppression with monoclonal antibodies. A model to determine the rules for effective serotherapy.
    Cobbold SP; Thierfelder S; Waldmann H
    Mol Biol Med; 1983 Oct; 1(3):285-304. PubMed ID: 6209527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
    Ramakrishnan S; Houston LL
    Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of autoimmune MRL/Ipr mice with monoclonal antibody to Thy-1.2: a single injection has sustained effects on lymphoproliferation and renal disease.
    Seaman WE; Wofsy D; Greenspan JS; Ledbetter JA
    J Immunol; 1983 Apr; 130(4):1713-8. PubMed ID: 6187819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface markers of T cells causing lethal graft-vs-host disease to class I vs class II H-2 differences.
    Korngold R; Sprent J
    J Immunol; 1985 Nov; 135(5):3004-10. PubMed ID: 3876371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of antibody isotype on passive serotherapy of lymphoma.
    Denkers EY; Badger CC; Ledbetter JA; Bernstein ID
    J Immunol; 1985 Sep; 135(3):2183-6. PubMed ID: 2862210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow transplantation across major histocompatability barriers in mice. III. Treatment of donor grafts with monoclonal antibodies directed against Lyt determinants.
    Vallera DA; Soderling CC; Kersey JH
    J Immunol; 1982 Feb; 128(2):871-5. PubMed ID: 6172513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine anti-mouse T cell monoclonal antibodies elicit anti-antibodies in mice: intra-species immunization model for estimating potential patient sensitization against humanized anti-T cell antibodies.
    Kremmer E; Mysliwietz J; Lederer R; Thierfelder S
    Eur J Immunol; 1993 May; 23(5):1017-22. PubMed ID: 8097469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies against T cell differentiation antigens initiate stimulation of monocyte/macrophage oxidative metabolism.
    Descamps-Latscha B; Golub RM; Nguyen AT; Feuillet-Fieux MN
    J Immunol; 1983 Nov; 131(5):2500-7. PubMed ID: 6195264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo or in vitro anti-CD3 epsilon chain monoclonal antibody therapy for the prevention of lethal murine graft-versus-host disease across the major histocompatibility barrier in mice.
    Blazar BR; Taylor PA; Vallera DA
    J Immunol; 1994 Apr; 152(7):3665-74. PubMed ID: 8144942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.